Vaccinex, Inc. (VCNX)
OTCMKTS · Delayed Price · Currency is USD
1.000
0.00 (0.00%)
At close: Nov 12, 2026
Vaccinex Market Cap
Vaccinex has a market cap or net worth of $2.68 million as of November 13, 2026. It is the 47,053rd most valuable company in the world and the 6,226th biggest in the United States. Its market cap has increased by 108.33% in one year.
Market Cap
2.68M
Enterprise Value
n/a
Revenue
601.00K
Global Rank
Country Rank
#6,226 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since August 9, 2018, Vaccinex's market cap has decreased from 130.58M to 2.68M, a decrease of -97.95%. That is a compound annual growth rate of -37.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 2.68M | -7.02% |
| Dec 31, 2025 | 2.88M | 9.74% |
| Dec 31, 2024 | 2.62M | -68.42% |
| Dec 29, 2023 | 8.31M | -74.16% |
| Dec 30, 2022 | 32.15M | 0.35% |
| Dec 31, 2021 | 32.03M | -30.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 9, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nymox Pharmaceutical | 3.68M |
| Institute of Biomedical Research | 3.30M |
| VitaSpring Biomedical | 3.21M |
| Abpro Holdings | 3.12M |
| Pacific Software | 3.12M |
| Orgenesis | 2.94M |
| Bioxytran | 2.64M |
| BioAtla | 2.60M |